PMID- 25315164 OWN - NLM STAT- MEDLINE DCOM- 20150824 LR - 20240117 IS - 1532-429X (Electronic) IS - 1097-6647 (Print) IS - 1097-6647 (Linking) VI - 16 IP - 1 DP - 2014 Oct 1 TI - High-resolution 3-dimensional late gadolinium enhancement scar imaging in surgically corrected Tetralogy of Fallot: clinical feasibility of volumetric quantification and visualization. PG - 76 LID - 10.1186/s12968-014-0076-y [doi] LID - 76 AB - BACKGROUND: The extent of surgical scarring in Tetralogy of Fallot (TOF) may be a marker of adverse outcomes and provide substrate for ventricular arrhythmia. In this study we evaluate the feasibility of high resolution three dimensional (3D) late gadolinium enhancement (LGE) cardiovascular magnetic resonance (CMR) for volumetric scar quantification in patients with surgically corrected TOF. METHODS: Fifteen consecutive patients underwent 3D LGE imaging with 3 Tesla CMR using a whole-heart, respiratory-navigated technique. A novel, signal-histogram based segmentation technique was tested for the quantification and modeling of surgical scar. Total scar volume was compared to the gold standard manual expert segmentation. The feasibility of segmented scar fusion to matched coronary CMR data for volumetric display was explored. RESULTS: Image quality sufficient for 3D scar segmentation was acquired in fourteen patients. Mean patient age was 32.2 +/- 11.9 years (range 21 to 57 years) with mean right ventricle (RV) ejection fraction (EF) of 53.9 +/- 9.2% and mean RV end diastolic volume of 117.0 +/- 41.5 mL/m(2). The mean total scar volume was 11.1 +/- 8.2 mL using semi-automated 3D segmentation with excellent correlation to manual expert segmentation (r = 0.99, bias = 0.89 mL, 95% CI -1.66 to 3.44). The mean segmentation time was significantly reduced using the novel semi-automated segmentation technique (10.1 +/- 2.6 versus 45.8 +/- 12.6 minutes). Excellent intra-observer and good inter-observer reproducibility was observed. CONCLUSION: 3D high resolution LGE imaging with semi-automated scar segmentation is clinically feasible among patients with surgically corrected TOF and shows excellent accuracy and reproducibility. This approach may offer a valuable clinical tool for risk prediction and procedural planning among this growing population. FAU - Stirrat, John AU - Stirrat J AD - Imaging Laboratories, Robarts Research Institute, Western University, London, Ontario, Canada. jstirrat2015@meds.uwo.ca. FAU - Rajchl, Martin AU - Rajchl M AD - Imaging Laboratories, Robarts Research Institute, Western University, London, Ontario, Canada. mrajchl@robarts.ca. FAU - Bergin, Lynn AU - Bergin L AD - Division of Cardiology, Department of Medicine, Western University, Calgary, Canada. Lynn.Bergin@lhsc.on.ca. FAU - Patton, David J AU - Patton DJ AD - Cardiac Imaging Centre, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada. David.Patton@albertahealthservices.ca. AD - Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada. David.Patton@albertahealthservices.ca. FAU - Peters, Terry AU - Peters T AD - Imaging Laboratories, Robarts Research Institute, Western University, London, Ontario, Canada. tpeters@robarts.ca. FAU - White, James A AU - White JA AD - Division of Cardiology, Department of Medicine, Western University, Calgary, Canada. jawhit@ucalgary.ca. AD - Cardiac Imaging Centre, Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada. jawhit@ucalgary.ca. AD - Division of Cardiology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada. jawhit@ucalgary.ca. LA - eng PT - Evaluation Study PT - Journal Article DEP - 20141001 PL - England TA - J Cardiovasc Magn Reson JT - Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance JID - 9815616 RN - 0 (Contrast Media) RN - 0 (Organometallic Compounds) RN - 1BJ477IO2L (gadobutrol) SB - IM MH - Adult MH - Automation MH - *Cardiac Surgical Procedures MH - Cicatrix/*diagnosis/etiology/pathology MH - *Contrast Media MH - Feasibility Studies MH - Female MH - Humans MH - Image Interpretation, Computer-Assisted/*methods MH - Imaging, Three-Dimensional/*methods MH - Magnetic Resonance Imaging, Cine/*methods MH - Male MH - Middle Aged MH - Myocardium/*pathology MH - Observer Variation MH - *Organometallic Compounds MH - Predictive Value of Tests MH - Reproducibility of Results MH - Tetralogy of Fallot/complications/diagnosis/*surgery MH - Treatment Outcome MH - Young Adult PMC - PMC4180957 EDAT- 2014/10/16 06:00 MHDA- 2015/08/25 06:00 PMCR- 2014/10/01 CRDT- 2014/10/16 06:00 PHST- 2014/01/31 00:00 [received] PHST- 2014/08/28 00:00 [accepted] PHST- 2014/10/16 06:00 [entrez] PHST- 2014/10/16 06:00 [pubmed] PHST- 2015/08/25 06:00 [medline] PHST- 2014/10/01 00:00 [pmc-release] AID - S1097-6647(23)00143-6 [pii] AID - 76 [pii] AID - 10.1186/s12968-014-0076-y [doi] PST - epublish SO - J Cardiovasc Magn Reson. 2014 Oct 1;16(1):76. doi: 10.1186/s12968-014-0076-y.